Calmare Therapeutics (PK) Stock Price - CTTC

0.12
-0.005 (-4.00%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Calmare Therapeutics Inc (PK) CTTC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.005 -4.0% 0.12 0.10 0.12 0.1075 0.125 16:01:42
Bid Price Ask Price Spread Spread % News
0.081 0.12 0.039 32.5% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5 85,820 $ 0.103469 $ 8,880 17,572 0.028 - 0.2374
Last Trade Time Type Quantity Stock Price Currency
15:50:50 200 $ 0.12 USD

Calmare Therapeutics (PK) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.65M 30.38M $ -3.83M - - 22.36M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
4.62k $ - 0.00% - -

more financials information »

Calmare Therapeutics (PK) News

Loading Messages....

Latest CTTC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTTC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.1010.14440.100.11925828,1210.01918.81%
1 Month0.14480.16240.090.125781614,430-0.0248-17.13%
3 Months0.0780.1980.0610.126925220,9700.04253.85%
6 Months0.129750.1980.0610.126335715,836-0.00975-7.51%
1 Year0.060.23740.0280.11748714,5060.06100.0%
3 Years0.1110.23740.01110.107941715,0060.0098.11%
5 Years0.205050.490.01110.177333117,843-0.08505-41.48%

Calmare Therapeutics (PK) Description

Calmare Therapeutics Incorporated, the Calmare Pain Mitigation Therapy company, researches, develops and commercializes chronic, neuropathic pain and wound affliction devices. Our flagship medical device - the Calmare Pain Therapy Device (the Calmare Device) is the world's only non-invasive and non-addictive modality that can successfully treat chronic, neuropathic pain. The Company holds a U.S. Food & Drug Administration 510k clearance designation on its flagship device, which grants it the exclusive right to sell, market, research and develop the medical device in the United States. Calmare Devices are commercially sold to medical practices throughout the world. They are also found in U.S. military hospitals, clinics and on installations via CTI's General Services Administration (GSA) military contract (V797P-4300B).


Your Recent History
USOTC
CTTC
Calmare Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.